MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2011-04-17 for ONCOTYPE DX * manufactured by Genomic Health.
[1948528]
This discrepancy in her2 test result was brought to my attention by an oncologist. The oncotype test, (b)(6) reported her2 as negative 9. 1 units, negative <10. 7, whereas our fish lab reported the her2 as equivocal with a ratio of 1. 99. There is potential pt harm if this pt is denied targeted her2 therapy on the basis of the oncotype test result.
Patient Sequence No: 1, Text Type: D, B5
Report Number | MW5020297 |
MDR Report Key | 2065662 |
Date Received | 2011-04-17 |
Date of Report | 2011-04-17 |
Date of Event | 2011-03-31 |
Date Added to Maude | 2011-04-26 |
Event Key | 0 |
Report Source Code | Voluntary report |
Manufacturer Link | N |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 0 |
Health Professional | 0 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 0 |
Single Use | 0 |
Previous Use Code | 0 |
Event Type | 3 |
Type of Report | 3 |
Brand Name | ONCOTYPE DX |
Generic Name | ONCOTYPE DX |
Product Code | NPQ |
Date Received | 2011-04-17 |
Model Number | * |
Catalog Number | * |
Lot Number | * |
ID Number | * |
Operator | OTHER |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | GENOMIC HEALTH |
Manufacturer Address | 301 PENOBSCOTT DR REDWOOD CITY CA 94063 US 94063 |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 2011-04-17 |